36 research outputs found
Increased Responsiveness of Human Coronary Artery Endothelial Cells in Inflammation and Coagulation
Get PDFThe effects of anti-inflammatory plant extracts, such as black tea extract (BTE) and resveratrol (RSV) could modulate cell activation leading to atherosclerosis, however there is little comparative information about how different endothelial cell types are affected by these compounds. In order to compare human endothelial cells derived from different origins (umbilical vein or HUVEC, coronary artery or HCAEC, microvascular or HMVEC) and their interleukin-1β (IL-1β) responsiveness, IL-6 ELISA, RT-PCR, tissue factor assay, and prostacyclin responses using 6-keto PGF1α ELISA were determined. The IL-1β-induced IL-6 levels were dose-dependent with highest responses seen in HCAEC. Significant inhibition of IL-1β responses was achieved with BTE and RSV, with the largest decrease of IL-6 and TF seen in HCAEC. Prostacyclin levels were highest in HUVEC and were inhibited by RSV in all cell types. The differences between the endothelial cell types could account for greater susceptibility of coronary arteries to inflammation and atherogenesis
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.
Get PDFObjectives To determine whether progressive skin fibrosis is associated with visceral organ progression and mortality during follow-up in patients with diffuse cutaneous systemic sclerosis (dcSSc). Methods We evaluated patients from the European Scleroderma Trials and Research database with dcSSc, baseline modified Rodnan skin score (mRSS) ≥7, valid mRSS at 12±3 months after baseline and ≥1 annual follow-up visit. Progressive skin fibrosis was defined as an increase in mRSS >5 and ≥25% from baseline to 12±3 months. Outcomes were pulmonary, cardiovascular and renal progression, and all-cause death. Associations between skin progression and outcomes were evaluated by Kaplan-Meier survival analysis and multivariable Cox regression. Results Of 1021 included patients, 78 (7.6%) had progressive skin fibrosis (skin progressors). Median follow-up was 3.4 years. Survival analyses indicated that skin progressors had a significantly higher probability of FVC decline ≥10% (53.6% vs 34.4%; p<0.001) and all-cause death (15.4% vs 7.3%; p=0.003) than non-progressors. These significant associations were also found in subgroup analyses of patients with either low baseline mRSS (≤22/51) or short disease duration (≤15 months). In multivariable analyses, skin progression within 1 year was independently associated with FVC decline ≥10% (HR 1.79, 95% CI 1.20 to 2.65) and all-cause death (HR 2.58, 95% CI 1.31 to 5.09). Conclusions Progressive skin fibrosis within 1 year is associated with decline in lung function and worse survival in dcSSc during follow-up. These results confirm mRSS as a surrogate marker in dcSSc, which will be helpful for cohort enrichment in future trials and risk stratification in clinical practice
15+ MILLION TOP 1% MOST CITED SCIENTIST 12.2% AUTHORS AND EDITORS FROM TOP 500 UNIVERSITIES Chapter from the book Acute Phase Proteins -Regulation and Functions of Acute Phase Proteins Downloaded from: http://www.intechopen.com/books/acute-phase-proteins-
No full text
Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome.
No full textInternational audienceBACKGROUND/PURPOSE: Primary Sjögren's syndrome (SS) is a chronic autoimmune disease primarily involving the exocrine glands. The clinical picture of SS ranges from exocrinopathy to systemic disease affecting the lung, kidney, liver, skin, musculockeletal and nervous systems. The morbidity of SS is mainly determined by extraglandular disease and increased prevalence of lymphoma. Environmental and hormonal factors, such as vitamin-D may play a role in the pathogenic process and disease expression. Thus, we aimed to evaluate levels of vitamin-D and their association with manifestations of SS. METHODS: Vitamin-D levels were determined in 176 primary SS patients and 163 matched healthy volunteers utilizing the LIAISON chemiluminescent immunoassays (DiaSorin-Italy). A correlation between vitamin-D levels and clinical and serological manifestations of SS was performed. RESULTS: Mean vitamin-D levels were comparable between SS patients and control 21.2 ± 9.4 ng/ml and 22.4 ± 10 ng/ml, respectively. Peripheral neuropathy was diagnosed in 23% of SS patients and associated with lower vitamin-D levels (18.6 ± 5.5 ng/ml vs. 22.6±8 ng/ml (p = 0.04)). Lymphoma was diagnosed in 4.3% of SS patients, who had lower levels of vitamin-D (13.2 ± 6.25 ng/ml), compared to SS patients without lymphoma (22 ± 8 ng/ml), (p = 0.03). Other clinical and serological manifestations did not correlate with vitamin-D status. CONCLUSIONS: In this study, low levels of vitamin-D correlated with the presence of peripheral neuropathy and lymphoma among SS patients. The link between vitamin-D and neuropathy or lymphoma was reported in other conditions, and may support a role for vitamin-D in the pathogenesis of these processes. Plausible beneficial effect for vitamin-D supplementation may thus be suggested
Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome
No full textBackground/purpose: Primary Sjogren’s syndrome (SS) is a chronic
autoimmune disease primarily involving the exocrine glands. The clinical
picture of SS ranges from exocrinopathy to systemic disease affecting
the lung, kidney, liver, skin, musculockeletal and nervous systems. The
morbidity of SS is mainly determined by extraglandular disease and
increased prevalence of lymphoma. Environmental and hormonal factors,
such as vitamin-D may play a role in the pathogenic process and disease
expression. Thus, we aimed to evaluate levels of vitamin-D and their
association with manifestations of SS.
Methods: Vitamin-D levels were determined in 176 primary SS patients and
163 matched healthy volunteers utilizing the LIAISON chemiluminescent
immunoassays (DiaSorin-Italy). A correlation between vitamin-D levels
and clinical and serological manifestations of SS was performed.
Results: Mean vitamin-D levels were comparable between SS patients and
control 21.2 +/- 9.4 ng/ml and 22.4 +/- 10 ng/ml, respectively.
Peripheral neuropathy was diagnosed in 23% of SS patients and
associated with lower vitamin-D levels (18.6 +/- 5.5 ng/ml vs. 22.6 +/-
8 ng/ml (p = 0.04)). Lymphoma was diagnosed in 4.3% of SS patients, who
had lower levels of vitamin-D (13.2 +/- 6.25 ng/ml), compared to SS
patients without lymphoma (22 +/- 8 ng/ml), (p = 0.03). Other clinical
and serological manifestations did not correlate with vitamin-D status.
Conclusions: In this study, low levels of vitamin-D correlated with the
presence of peripheral neuropathy and lymphoma among SS patients. The
link between vitamin-D and neuropathy or lymphoma was reported in other
conditions, and may support a role for vitamin-D in the pathogenesis of
these processes. Plausible beneficial effect for vitamin-D
supplementation may thus be suggested. (C) 2012 Elsevier Ltd. All rights
reserved
Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients
No full text
